ORIGINAL RESEARCH article
Front. Med.
Sec. Pulmonary Medicine
Development and internal validation of a machine learning–based prediction model for pulmonary hypertension in COPD
Provisionally accepted- 1Beijing Chaoyang Hospital Affiliated to Capital Medical University Department of Respiratory and Critical Care Medicine, Beijing, China
- 2Guangdong University of Technology, Guangzhou, China
- 3Beijing Chaoyang Hospital Affiliated to Capital Medical University Department of Radiology, Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Chronic obstructive pulmonary disease (COPD) is frequently complicated by pulmonary hypertension (PH), which worsens prognosis, but early PH detection is limited by the invasiveness or suboptimal sensitivity of current diagnostic tools. Methods: In this retrospective study, we analyzed 523 hospitalized patients with COPD from Beijing Chaoyang Hospital. After standardized preprocessing and recursive feature elimination, 18 routinely available noninvasive clinical and physiological variables were retained as predictors. Eight machine-learning algorithms were trained to predict PH and compared using area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, F1 score, and decision-curve analysis; model interpretability was assessed with Shapley additive explanations (SHAP). Results: The CatBoost model showed the best discrimination (AUC 0.848; accuracy 0.830; sensitivity 0.758; specificity 0.866; F1 0.746). SHAP analysis identified right ventricular diameter, pulmonary artery diameter, arterial partial pressure of carbon dioxide, right atrial transverse diameter, and age as the most influential predictors. Conclusions: A CatBoost-based prediction model using readily obtainable noninvasive variables can estimate PH risk in COPD with good accuracy and provide transparent feature-level explanations, potentially facilitating earlier detection and risk-stratified management.
Keywords: CatBoost algorithm4, chronic obstructive pulmonary disease1, Clinical prediction mode6, feature selection7, Machine Learning3, pulmonary hypertension2, SHAP5
Received: 22 Nov 2025; Accepted: 02 Feb 2026.
Copyright: © 2026 Wang, Tan, Li, Pan, Guo, Wei and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jing Wang
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
